TD Cowen analyst Phil Nadeau maintained a Buy rating on Atara Biotherapeutics (ATRA – Research Report) yesterday. The company’s shares closed ...
Hosted on MSN2mon
Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's WhyAtara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
Hosted on MSN1mon
Airbus’ A320 ATRA with Eurofighter nose completes first flightAirbus has revealed the completion of 'first flight' for German Aerospace Center's (DLR) modified Airbus A320 advanced technology research aircraft (ATRA) for the E-Scan radar project. This ...
Las Vegas ranked 10th in media markets with the highest spending on legal services advertising and 8th in media markets with ...
Atara Biotherapeutics (ATRA) came out with a quarterly loss of $1.19 per share versus the Zacks Consensus Estimate of a loss of $3.82. This compares to loss of $14 per share a year ago.
The Ministry of Communication and Information Technology (MoCIT) has announced companies importing mobile phones are required ...
Stifel Nicolaus analyst Benjamin Burnett maintained a Hold rating on Atara Biotherapeutics (ATRA – Research Report) yesterday and set a price ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The American Tort Reform Association (ATRA) praised South Carolina Governor Henry McMaster following a press conference on the state's liability laws Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results